September 20, 2011
MSD K.K. and Ono Pharmaceutical announced on September 16 that the two companies received on the same day approval for an additional indication for the oral type 2 diabetes treatment sitagliptin (brand name in Japan: Januvia (MSD) and Glactiv (Ono))...read more